A budget impact model and a cost-utility analysis of reducer device (Neovasc) in patients with refractory angina.

MLA

Fortunato, Agostino, et al. “A Budget Impact Model and a Cost-Utility Analysis of Reducer Device (Neovasc) in Patients with Refractory Angina.” Frontiers in Cardiovascular Medicine, Apr. 2024, pp. 1–12. EBSCOhost, https://doi.org/10.3389/fcvm.2024.1307534.

APA

Fortunato, A., Valentini, I., Rumi, F., Antonini, D., Siviero, L., Di Brino, E., Basile, M., & Cicchetti, A. (2024). A budget impact model and a cost-utility analysis of reducer device (Neovasc) in patients with refractory angina. Frontiers in Cardiovascular Medicine, 1–12. https://doi.org/10.3389/fcvm.2024.1307534

Chicago

Fortunato, Agostino, Ilaria Valentini, Filippo Rumi, Debora Antonini, Ludovica Siviero, Eugenio Di Brino, Michele Basile, and Americo Cicchetti. 2024. “A Budget Impact Model and a Cost-Utility Analysis of Reducer Device (Neovasc) in Patients with Refractory Angina.” Frontiers in Cardiovascular Medicine, April, 1–12. doi:10.3389/fcvm.2024.1307534.